St. Jude Medical, Inc. (NYSE: STJ) announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE